Innovative Technology RegGenome leverages advanced AI and machine-readable data processing to revolutionize regulatory information management, presenting opportunities to partner with organizations seeking cutting-edge compliance tools and regulatory automation solutions.

Strategic Funding Growth With a recent $6 million seed investment from prominent investors including Mastercard and Cambridge Enterprise, RegGenome demonstrates strong financial backing and growth potential, indicating readiness to scale operations and expand market reach.

Research University Roots Emerging from collaboration with the University of Cambridge, the company has access to academic partnerships and innovation hubs, creating sales opportunities within research institutions and organizations seeking university-backed regulatory solutions.

Mid-Sized Market Presence Operating with 11-50 employees and generating revenues between $1 million and $10 million, RegGenome is positioned as a growing player in the regulatory data sector, suitable for B2B sales targeting mid-market firms and compliance-heavy industries.

Expanding Regulatory Data Focus As a leader in computational regulation, RegGenome’s offerings are highly relevant to companies in life sciences, healthcare, and biotech sectors that require sophisticated regulatory intelligence and data processing, presenting targeted sales opportunities in these fields.